Strain identifier

BacDive ID: 157078

Type strain: No

Species: Streptococcus pneumoniae

NCBI tax ID(s): 1313 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 9.3 (current version):
version 9.2:
version 9.1:
version 9:
version 8.1:
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 9.3 (current version)

General

@ref: 63580

BacDive-ID: 157078

keywords: genome sequence, Bacteria, microaerophile, mesophilic

description: Streptococcus pneumoniae CCUG 69382 is a microaerophile, mesophilic bacterium that was isolated from Human,blood.

NCBI tax id

  • NCBI tax id: 1313
  • Matching level: species

doi: 10.13145/bacdive157078.20250331.9.3

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/bacillota
  • domain: Bacteria
  • phylum: Bacillota
  • class: Bacilli
  • order: Lactobacillales
  • family: Streptococcaceae
  • genus: Streptococcus
  • species: Streptococcus pneumoniae
  • full scientific name: Streptococcus pneumoniae (Klein 1884) Chester 1901 (Approved Lists 1980)
  • synonyms

    @refsynonym
    20215Micrococcus pneumoniae
    20215Staphylococcus pneumoniae

@ref: 63580

domain: Bacteria

phylum: Firmicutes

class: Bacilli

order: Lactobacillales

family: Streptococcaceae

genus: Streptococcus

species: Streptococcus pneumoniae

type strain: no

Morphology

cell morphology

@refmotilityconfidencegram stain
125438no90
12543890.591positive

Culture and growth conditions

culture temp

  • @ref: 63580
  • growth: positive
  • type: growth
  • temperature: 37

Physiology and metabolism

oxygen tolerance

@refoxygen toleranceconfidence
63580microaerophile
125439microaerophile99

spore formation

  • @ref: 125439
  • spore formation: no
  • confidence: 91.7

Isolation, sampling and environmental information

isolation

  • @ref: 63580
  • sample type: Human,blood
  • sampling date: 1991
  • geographic location: Tennessee
  • country: USA
  • origin.country: USA
  • continent: North America

isolation source categories

Cat1Cat2Cat3
#Host#Human
#Host Body Product#Fluids#Blood
#Infection#Patient

Sequence information

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Streptococcus pneumoniae CCUG 69382GCA_002014115scaffoldncbi1313
66792Streptococcus pneumoniae strain CCUG 693821313.13973wgspatric1313

Genome-based predictions

predictions

@refmodeltraitdescriptionpredictionconfidencetraining_data
125438gram-positivegram-positivePositive reaction to Gram-stainingyes90.591no
125438anaerobicanaerobicAbility to grow under anoxygenic conditions (including facultative anaerobes)no89.866yes
125438aerobicaerobicAbility to grow under oxygenic conditions (including facultative aerobes)no97.755yes
125438spore-formingspore-formingAbility to form endo- or exosporesno83.883no
125438thermophilethermophilicAbility to grow at temperatures above or equal to 45°Cno95yes
125438motile2+flagellatedAbility to perform flagellated movementno90no
125439BacteriaNetspore_formationAbility to form endo- or exosporesno91.7
125439BacteriaNetmotilityAbility to perform movementno86.4
125439BacteriaNetgram_stainReaction to gram-stainingpositive89
125439BacteriaNetoxygen_toleranceOxygenic conditions needed for growthmicroaerophile99

External links

@ref: 63580

culture collection no.: CCUG 69382, ATCC 51916

straininfo link

  • @ref: 110207
  • straininfo: 43245

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity16174686Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Linares J, Fernandez Viladrich P, Gudiol FJ Antimicrob Chemother10.1093/jac/dki3232005Animals, Ceftriaxone/administration & dosage/pharmacology/*therapeutic use, *Cephalosporin Resistance, Cerebrospinal Fluid/microbiology, Colony Count, Microbial, Disease Models, Animal, Drug Combinations, Drug Interactions, Drug Resistance, Bacterial, Female, Meningitis, Pneumococcal/*drug therapy/microbiology, Microbial Sensitivity Tests, Rabbits, Rifampin/administration & dosage/pharmacology/*therapeutic use, Streptococcus pneumoniae/*drug effects, Vancomycin/administration & dosage/pharmacology/*therapeutic use
Enzymology16507562Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Linares J, Viladrich PF, Gudiol FJ Antimicrob Chemother10.1093/jac/dkl0472006Animals, *Anti-Bacterial Agents/pharmacokinetics/pharmacology/therapeutic use, Ceftriaxone/pharmacokinetics/pharmacology/therapeutic use, Cephalosporin Resistance/*drug effects, Disease Models, Animal, Drug Synergism, Drug Therapy, Combination, Female, Fosfomycin/pharmacokinetics/pharmacology/therapeutic use, Meningitis, Pneumococcal/blood/*drug therapy, Microbial Sensitivity Tests, Rabbits, Streptococcus pneumoniae/*drug effects, Vancomycin/pharmacokinetics/pharmacology/therapeutic usePathogenicity
Pathogenicity24962033Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.Vivas M, Force E, Garrigos C, Tubau F, Platteel AC, Ariza J, Cabellos CJ Antimicrob Chemother10.1093/jac/dku2312014Animals, Cephalosporin Resistance/*drug effects, Cephalosporins/pharmacology/*therapeutic use, Daptomycin/pharmacology/*therapeutic use, Female, Meningitis, Pneumococcal/cerebrospinal fluid/*drug therapy, Rabbits, Treatment Outcome
Enzymology25813395Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.Vivas M, Force E, Tubau F, El Haj C, Ariza J, Cabellos CInt J Antimicrob Agents10.1016/j.ijantimicag.2015.01.0142015Animals, Anti-Bacterial Agents/pharmacokinetics/pharmacology/*therapeutic use, Bacterial Load, Cerebrospinal Fluid/chemistry, Daptomycin/pharmacokinetics/pharmacology/*therapeutic use, Dexamethasone/pharmacology/*therapeutic use, Drug Resistance, Bacterial, Drug Therapy, Combination, Meningitis, Pneumococcal/*drug therapy, Microbial Sensitivity Tests, Rabbits, Streptococcus pneumoniae, Treatment Outcome

Reference

@idauthorstitledoi/urlcatalogue
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ10.1099/ijsem.0.004332
63580Curators of the CCUGhttps://www.ccug.se/strain?id=69382Culture Collection University of Gothenburg (CCUG) (CCUG 69382)
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg OvermannAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)https://diaspora-project.de/progress.html#genomes
110207Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.StrainInfo: A central database for resolving microbial strain identifiers10.60712/SI-ID43245.1
125438Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg OvermannPredicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets10.1101/2024.08.12.607695
125439Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardydeepG: Deep Learning for Genome Sequence Data. R package version 0.3.1https://github.com/GenomeNet/deepG